Diagnostic performance of increased prolidase activity in schizophrenia.

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Neuroscience Letters

• Publication date

  2016-02-02

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1016/j.neulet.2015.12.036PMID 26724223
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• ACE I/D genotype-related increase in ACE plasma activity is a better predictor for schizophrenia diagnosis than the genotype alone.

  2015cited by this paper
• Prolidase activity and oxidative stress in patients with schizophrenia: a preliminary study.

  2015influential reference
• Diagnostic utility of quantitative EEG in un-medicated schizophrenia.

  2015cited by this paper
• Altered microRNA Expression in Peripheral Blood Mononuclear Cells from Young Patients with Schizophrenia

  2015cited by this paper
• Relationship of cognitive performance with prolidase and oxidative stress in Alzheimer disease

  2013cited by this paper
• Plasma Ndel1 enzyme activity is reduced in patients with schizophrenia--a potential biomarker?

  2013cited by this paper
• Behavioral and neurochemical effects of proline

  2011cited by this paper
• The role of NGF and IL-2 serum level in assisting the diagnosis in first episode schizophrenia.

  2011cited by this paper
• Metabolome in schizophrenia and other psychotic disorders: a general population-based study

  2011cited by this paper
• Prolidase activity and its diagnostic performance in bipolar disorder.

  2011influential reference
• Proline and hydroxyproline metabolism: implications for animal and human nutrition

  2011cited by this paper
• Proline metabolism and microenvironmental stress.

  2010cited by this paper
• Synapse Pathology in Psychiatric and Neurologic Disease

  2010cited by this paper
• Validation of a Blood-Based Laboratory Test to Aid in the Confirmation of a Diagnosis of Schizophrenia

  2010cited by this paper
• Dopamine vs Noradrenaline: Inverted-U Effects and ADHD Theories

  2009influential reference
• Prefrontal cognitive systems in schizophrenia : Towards human genetic brain mechanisms

  2009influential reference
• A risk PRODH haplotype affects sensorimotor gating, memory, schizotypy, and anxiety in healthy male subjects.

  2009cited by this paper
• A Defect in the Antioxidant Defense System in Schizophrenia

  2009cited by this paper
• The association of serum prolidase activity with the presence and severity of coronary artery disease

  2008cited by this paper
• Inborn errors of proline metabolism.

  2008cited by this paper
• Proline metabolism in health and disease

  2008cited by this paper
• Serum prolidase activity in patients with hypertension and its relation with left ventricular hypertrophy.

  2007cited by this paper
• Cell–matrix adhesion

  2007cited by this paper
• Glutamate and schizophrenia: phencyclidine, N-methyl-D-aspartate receptors, and dopamine-glutamate interactions.

  2007cited by this paper
• Involvement of hyperprolinemia in cognitive and psychiatric features of the 22q11 deletion syndrome.

  2007cited by this paper
• Antioxidant enzymes and lipid peroxidation in different forms of schizophrenia treated with typical and atypical antipsychotics.

  2006cited by this paper
• Hyperprolinemia is a risk factor for schizoaffective disorder

  2005cited by this paper
• Matrix Metalloproteinases: Pathways of Induction by Bioactive Molecules

  2004cited by this paper
• Variants in the catechol-o-methyltransferase (COMT) gene are associated with schizophrenia in Irish high-density families

  2004influential reference
• Neurotrophic factors and the pathophysiology of schizophrenic psychoses

  2004cited by this paper
• Is the Arginine-Nitric Oxide Pathway Involved in the Pathogenesis of Schizophrenia?

  2003cited by this paper
• In vivo and in vitro effects of proline on some parameters of oxidative stress in rat brain.

  2003cited by this paper
• Schizophrenia as a complex trait: evidence from a meta-analysis of twin studies.

  2003cited by this paper
• NMDA receptor antagonist effects, cortical glutamatergic function, and schizophrenia: toward a paradigm shift in medication development

  2003cited by this paper
• Sensitivity and specificity of select biological indices in characterizing psychotic patients and their relatives.

  2003cited by this paper
• Serum prolidase activity as a marker of osteoporosis in type 2 diabetes mellitus.

  2002cited by this paper
• PRODH mutations and hyperprolinemia in a subset of schizophrenic patients.

  2002cited by this paper
• The possible pathophysiological role of plasma nitric oxide and adrenomedullin in schizophrenia.

  2002cited by this paper
• Schizophrenia: Diverse Approaches to a Complex Disease

  2002cited by this paper
• Evidence that the activities of erythrocyte free radical scavenging enzymes and the products of lipid peroxidation are increased in different forms of schizophrenia

  2001cited by this paper
• The gene encoding proline dehydrogenase modulates sensorimotor gating in mice

  1999cited by this paper
• Localization of the brain-specific high-affinity l-proline transporter in cultured hippocampal neurons: molecular heterogeneity of synaptic terminals.

  1999cited by this paper
• Review article: the role of inflammation in the pathogenesis of gastric cancer

  1999cited by this paper
• Proline-induced potentiation of glutamate transmission.

  1997cited by this paper
• Association of hyperprolinaemia type I and heparin cofactor II deficiency with CATCH 22 syndrome: evidence for a contiguous gene syndrome locating the proline oxidase gene

  1996cited by this paper
• Spurious precision: procedural validity of diagnostic assessment in psychotic disorders.

  1995cited by this paper
• Prolidase deficiency: biochemical study of erythrocyte and skin fibroblast prolidase activity in Italian patients.

  1994cited by this paper
• Schizophrenia: manifestations, incidence and course in different cultures. A World Health Organization ten-country study.

  1992cited by this paper
• Oxygen and wound healing.

  1990cited by this paper
• The positive and negative syndrome scale (PANSS) for schizophrenia.

  1987influential reference
• Determination of prolinase activity in plasma. Application to liver disease and its relation with prolidase activity.

  1985cited by this paper
• PROLIDASE ACTIVITY IN BRAIN: COMPARISON WITH OTHER ORGANS

  1978cited by this paper
• Postmortem changes in the cerebral free amino acid pool.

  1974cited by this paper

• Evaluation of Inflammatory and Oxidative Markers and Their Diagnostic Value in Schizophrenia

  2025cites this paper
• Assessing the relationship between antipsychotic drug use and prolidase enzyme activity and oxidative stress in schizophrenia patients: a case-control study

  2023cites this paper
• Prolidase activity in adult bipolar disorder patient: a case - control study

  2023cites this paper
• Peripheral Complement Factor-Based Biomarkers for Patients with First-Episode Schizophrenia

  2023cites this paper
• Nano-hesperetin attenuates ketamine-induced schizophrenia-like symptoms in mice: participation of antioxidant parameters

  2023cites this paper
• Serum NOX1 and Raftlin as New Potential Biomarkers of Interest in Schizophrenia: A Preliminary Study

  2022cites this paper
• Serum NOX1 and Raftlin as New Potential Biomarkers of Interest in Schizophrenia: A Preliminary Study

  2022cites this paper
• PROLIDASE: A Review from Discovery to its Role in Health and Disease

  2021cites this paper
• Diagnostic Performance of Increased Malondialdehyde Level and Oxidative Stress in Patients with Schizophrenia

  2021cites this paper
• Current Understanding of the Emerging Role of Prolidase in Cellular Metabolism

  2020cites this paper
• ALDH4A1 expression levels are elevated in postmortem brains of patients with schizophrenia and are associated with genetic variants in enzymes related to proline metabolism.

  2020cites this paper
• Increased prolidase activity in Alzheimer's dementia: A case-control study.

  2020cites this paper
• Plasma prolidase levels are high in schizophrenia but not in first-episode psychosis

  2020cites this paper
• Prolidase - A protein with many faces.

  2020cites this paper
• Evaluation Serum Levels of G Protein-Coupled Estrogen Receptor and Its Diagnostic Value in Patients With Schizophrenia

  2020cites this paper
• Diagnostıc Performance Of Erythropoetin And Erythropoetin Receptor Levels In Patients With Generalized Anxiety Disorder

  2020cites this paper
• Increased prolidase activity and high blood monocyte counts in pediatric bipolar disorder.

  2019cites this paper
• A Novel Role of Prolidase in Cocaine-Mediated Breach in the Barrier of Brain Microvascular Endothelial Cells

  2019cites this paper
• Assessment of malondialdehyde levels, superoxide dismutase, and catalase activity in children with autism spectrum disorders

  2018cites this paper
• Plasma prolidase levels as a biomarker for polycystic ovary syndrome.

  2018cites this paper
• Elevated serum levels of malondialdehyde and cortisol are associated with major depressive disorder: A case-control study

  2018cites this paper
• The Diagnostic Value of Malondialdehyde, Superoxide Dismutase and Catalase Activity in Drug Naïve, First Episode, Non-Smoker Generalized Anxiety Disorder Patients

  2018cites this paper
• Substrate specificity and reaction mechanism of human prolidase

  2017cites this paper
• Serum levels of G protein-coupled estrogen receptor 1 (GPER1) in drug-naive patients with generalized anxiety disorder.

  2016cites this paper
• Evaluation of malondialdehyde, superoxide dismutase and catalase activity and their diagnostic value in drug naïve, first episode, non-smoker major depression patients and healthy controls.

  2016cites this paper
• Evaluation of Paraoxonase, Arylesterase and Malondialdehyde Levels in Schizophrenia Patients Taking Typical, Atypical and Combined Antipsychotic Treatment

  2016cites this paper